The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Challenge of Modulating Heparan Sulfate Turnover by Multitarget Heparin Derivatives
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 2, Pages 390
Publisher
MDPI AG
Online
2020-01-17
DOI
10.3390/molecules25020390
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between tumor cells and lymphocytes modulates heparanase expression
- (2019) Thérèse Rachell Theodoro et al. Journal of Translational Medicine
- Low-Molecular-Weight Heparin in Cancer Patients: Overview and Indications
- (2019) Minna Voigtlaender et al. Hamostaseologie
- Glycosaminoglycans and Glycosaminoglycan Mimetics in Cancer and Inflammation
- (2019) Shravan Morla INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Glypican 3 Overexpression across a Broad Spectrum of Tumor Types Discovered with Functional Genomic mRNA Profiling of a Large Cancer Database
- (2018) Kirsten L. Moek et al. AMERICAN JOURNAL OF PATHOLOGY
- A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
- (2018) Keith Dredge et al. BRITISH JOURNAL OF CANCER
- Supersulfated low-molecular weight heparin synergizes with IGF1R/IR inhibitor to suppress synovial sarcoma growth and metastases
- (2018) Giuliana Cassinelli et al. CANCER LETTERS
- Pleiotropic effects of heparins: does anticoagulant treatment increase survival in cancer patients?
- (2018) I. García-Escobar et al. Clinical & Translational Oncology
- Tumor-dependent effects of proteoglycans and various glycosaminoglycan synthesizing enzymes and sulfotransferases on patients’ outcome
- (2018) Karthikeyan Subbarayan et al. CURRENT CANCER DRUG TARGETS
- Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy
- (2018) Monica Galli et al. HAEMATOLOGICA
- The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies
- (2018) Brooke L. Farrugia et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior
- (2018) Shyam K. Bandari et al. MATRIX BIOLOGY
- Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression
- (2018) Israel Vlodavsky et al. TRENDS IN BIOCHEMICAL SCIENCES
- Phase I study of the heparanase inhibitor Roneparstat: an innovative approach for multiple myeloma therapy
- (2018) Monica Galli et al. HAEMATOLOGICA
- Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
- (2018) Valeria De Pasquale et al. Molecular Therapy-Methods & Clinical Development
- Binding and neurotoxicity mitigation of toxic tau oligomers by synthetic heparin like oligosaccharides
- (2018) Peng Wang et al. CHEMICAL COMMUNICATIONS
- The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action
- (2018) Marina Weissmann et al. MATRIX BIOLOGY
- Facile saccharide-free mimetics that recapitulate key features of glycosaminoglycan sulfation patterns
- (2018) Teck Chuan Lim et al. Chemical Science
- Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells
- (2018) Srikanth Barkeer et al. BMC CANCER
- The role of innate immunity in mucopolysaccharide diseases
- (2018) Helen Parker et al. JOURNAL OF NEUROCHEMISTRY
- Necuparanib, a multi-targeting heparan sulfate mimetic, targets tumor and stromal compartments in pancreatic cancer
- (2018) Amanda MacDonald et al. MOLECULAR CANCER THERAPEUTICS
- A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation
- (2018) Rio S. Boothello et al. MOLECULAR CANCER THERAPEUTICS
- Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity
- (2018) Cinzia Lanzi et al. MOLECULES
- Axonal dystrophy in the brain of mice with Sanfilippo syndrome
- (2017) Helen Beard et al. EXPERIMENTAL NEUROLOGY
- Epigenetic Regulation of the Biosynthesis & Enzymatic Modification of Heparan Sulfate Proteoglycans: Implications for Tumorigenesis and Cancer Biomarkers
- (2017) Elizabeth Hull et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A novel conditional Sgsh knockout mouse model recapitulates phenotypic and neuropathic deficits of Sanfilippo syndrome
- (2017) Adeline A. Lau et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Proteoglycans remodeling in cancer: Underlying molecular mechanisms
- (2017) Achilleas D. Theocharis et al. MATRIX BIOLOGY
- Treatment of brain disease in the mucopolysaccharidoses
- (2017) Maurizio Scarpa et al. MOLECULAR GENETICS AND METABOLISM
- Chemoenzymatic synthesis of heparan sulfate and heparin oligosaccharides and NMR analysis: paving the way to a diverse library for glycobiologists
- (2017) Xing Zhang et al. Chemical Science
- α3 Chains of type V collagen regulate breast tumour growth via glypican-1
- (2017) Guorui Huang et al. Nature Communications
- Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer’s Disease
- (2017) Deepti Goyal et al. ACS Combinatorial Science
- Prognostic significance of heparanase expression in primary and metastatic breast carcinoma
- (2017) Olga Vornicova et al. Oncotarget
- Neurodevelopmental Changes in Excitatory Synaptic Structure and Function in the Cerebral Cortex of Sanfilippo Syndrome IIIA Mice
- (2017) Chrissa A. Dwyer et al. Scientific Reports
- Cellular internalization of alpha-synuclein aggregates by cell surface heparan sulfate depends on aggregate conformation and cell type
- (2017) Elisabet Ihse et al. Scientific Reports
- The heparanase/heparan sulfate proteoglycan axis: A potential new therapeutic target in sarcomas
- (2016) Giuliana Cassinelli et al. CANCER LETTERS
- Heparanase: From basic research to therapeutic applications in cancer and inflammation
- (2016) Israel Vlodavsky et al. DRUG RESISTANCE UPDATES
- Recent advances in the discovery of heparanase inhibitors as anti-cancer agents
- (2016) Li Jia et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Recent innovations in the structural analysis of heparin
- (2016) Edwin A. Yates et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Synthesis, radiolabeling with fluorine-18 and preliminary in vivo evaluation of a heparan sulphate mimetic as potent angiogenesis and heparanase inhibitor for cancer applications
- (2016) B. Kuhnast et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
- (2016) Marina Weissmann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heparanase is required for activation and function of macrophages
- (2016) Lilach Gutter-Kapon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer
- (2016) Shiwei Han et al. Oncotarget
- The prognostic significance of heparanase expression in metastatic melanoma
- (2016) Olga Vornicova et al. Oncotarget
- Heparanase and cancer progression: New directions, new promises
- (2016) Gil Arvatz et al. Human Vaccines & Immunotherapeutics
- Function from within: Autophagy induction by HPSE/heparanase—new possibilities for intervention
- (2015) Neta Ilan et al. Autophagy
- Neuronopathic lysosomal storage disorders: Approaches to treat the central nervous system
- (2015) Maurizio Scarpa et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Syntenin and syndecan in the biogenesis of exosomes
- (2015) Véronique Friand et al. BIOLOGY OF THE CELL
- HS3ST2 expression is critical for the abnormal phosphorylation of tau in Alzheimer’s disease-related tau pathology
- (2015) Julia Elisa Sepulveda-Diaz et al. BRAIN
- Heparanase Enhances Tumor Growth and Chemoresistance by Promoting Autophagy
- (2015) Anna Shteingauz et al. CANCER RESEARCH
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- (2015) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Extracellular matrix disruption is an early event in the pathogenesis of skeletal disease in mucopolysaccharidosis I
- (2015) Jonathan M. Heppner et al. MOLECULAR GENETICS AND METABOLISM
- Glypican-1 identifies cancer exosomes and detects early pancreatic cancer
- (2015) Sonia A. Melo et al. NATURE
- Targeting heparanase overcomes chemoresistance and diminishes relapse in myeloma
- (2015) Vishnu C. Ramani et al. Oncotarget
- Oversulfated heparins with low anticoagulant activity are strong and fast inhibitors of hepcidin expression in vitro and in vivo
- (2014) Maura Poli et al. BIOCHEMICAL PHARMACOLOGY
- The potential of heparanase as a therapeutic target in cancer
- (2014) Claudio Pisano et al. BIOCHEMICAL PHARMACOLOGY
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Shed syndecan-2 inhibits angiogenesis
- (2014) G. De Rossi et al. JOURNAL OF CELL SCIENCE
- The expression of heparanase in normal and preeclamptic placentas
- (2014) Shimon Ginath et al. Journal of Maternal-Fetal & Neonatal Medicine
- Insulin Receptor Antibody–Sulfamidase Fusion Protein Penetrates the Primate Blood–Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type A Cells
- (2014) Ruben J. Boado et al. MOLECULAR PHARMACEUTICS
- Heparanase expression in Langerhans cell histiocytosis
- (2014) Rina Dvir et al. PEDIATRIC BLOOD & CANCER
- Proteoglycans and Glycosaminoglycans in Misfolded Proteins Formation in Alzheimer’s Disease
- (2014) Peipei Wang et al. PROTEIN AND PEPTIDE LETTERS
- Heparanase multiple effects in cancer
- (2014) Yona Nadir et al. THROMBOSIS RESEARCH
- Towards Understanding the Roles of Heparan Sulfate Proteoglycans in Alzheimer’s Disease
- (2014) Gan-lin Zhang et al. Biomed Research International
- The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics
- (2014) Edward Hammond et al. Frontiers in Oncology
- Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models
- (2013) G. Cassinelli et al. BIOCHEMICAL PHARMACOLOGY
- Heparanase Regulates Secretion, Composition, and Function of Tumor Cell-derived Exosomes
- (2013) Camilla A. Thompson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heparan sulfate proteoglycan as a cell-surface endocytosis receptor
- (2013) Helena C. Christianson et al. MATRIX BIOLOGY
- Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
- (2013) B. B. Holmes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The overexpression of glypican-5 promotes cancer cell migration and is associated with shorter overall survival in non-small cell lung cancer
- (2013) YAN LI et al. Oncology Letters
- Expression of heparanase in vascular cells and astrocytes of the mouse brain after focal cerebral ischemia
- (2011) Jimei Li et al. BRAIN RESEARCH
- Local Retention Versus Systemic Release of Soluble VEGF Receptor-1 Are Mediated by Heparin-Binding and Regulated by Heparanase
- (2011) Shay Sela et al. CIRCULATION RESEARCH
- SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
- (2011) Joseph P. Ritchie et al. CLINICAL CANCER RESEARCH
- Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke
- (2011) Kim M. Baeten et al. Developmental Neurobiology
- Mucopolysaccharidosis Type I, Unique Structure of Accumulated Heparan Sulfate and IncreasedN-Sulfotransferase Activity in Mice Lacking α-l-iduronidase
- (2011) Rebecca J. Holley et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of Miglustat Treatment in Patients with Type III Mucopolysaccharidosis: A Randomized, Double-Blind, Placebo-Controlled Study
- (2011) Nathalie Guffon et al. JOURNAL OF PEDIATRICS
- Genetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome
- (2011) Sophie E. Winder-Rhodes et al. MOVEMENT DISORDERS
- Cognitive development in patients with Mucopolysaccharidosis type III (Sanfilippo syndrome)
- (2011) Marlies J Valstar et al. Orphanet Journal of Rare Diseases
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Heparanase-enhanced shedding of syndecan-1 by myeloma cells promotes endothelial invasion and angiogenesis
- (2010) A. Purushothaman et al. BLOOD
- Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
- (2010) Elina Sandwall et al. GLYCOBIOLOGY
- Heparanase 2 Interacts with Heparan Sulfate with High Affinity and Inhibits Heparanase Activity
- (2010) Flonia Levy-Adam et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Quantitative and Qualitative Alterations of Heparan Sulfate in Fibrogenic Liver Diseases and Hepatocellular Cancer
- (2010) Péter Tátrai et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
- (2009) K. Dredge et al. INVESTIGATIONAL NEW DRUGS
- Impact of Venous Thromboembolism and Anticoagulation on Cancer and Cancer Survival
- (2009) Nicole M. Kuderer et al. JOURNAL OF CLINICAL ONCOLOGY
- Syndecan-1 regulates αvβ3and αvβ5integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor
- (2009) DeannaLee M. Beauvais et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Hypoxia increases macrophage motility, possibly by decreasing the heparan sulfate proteoglycan biosynthesis
- (2009) Annika Asplund et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Identification of Heparin-binding Sites in Proteins by Selective Labeling
- (2009) Alessandro Ori et al. MOLECULAR & CELLULAR PROTEOMICS
- Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis
- (2009) H Lemjabbar-Alaoui et al. ONCOGENE
- Sanfilippo syndrome type B, a lysosomal storage disease, is also a tauopathy
- (2009) K. Ohmi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Heparanase: busy at the cell surface
- (2009) Liat Fux et al. TRENDS IN BIOCHEMICAL SCIENCES
- Lysosomal Storage Diseases and the Blood-Brain Barrier
- (2008) David Begley et al. CURRENT PHARMACEUTICAL DESIGN
- Assembly-dependent endocytosis and clearance of extracellular a-synuclein
- (2008) He-Jin Lee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Human Follicular Fluid Heparan Sulfate Contains Abundant 3-O-Sulfated Chains with Anticoagulant Activity
- (2008) Ariane I. de Agostini et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Decreased blood–brain barrier P-glycoprotein function in the progression of Parkinson’s disease, PSP and MSA
- (2008) A. L. Bartels et al. JOURNAL OF NEURAL TRANSMISSION
- Neuroprotective Properties of Glycosaminoglycans: Potential Treatment for Neurodegenerative Disorders
- (2008) B. Dudas et al. Neurodegenerative Diseases
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started